Avani A. Pendse

566 total citations
24 papers, 406 citations indexed

About

Avani A. Pendse is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Avani A. Pendse has authored 24 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Avani A. Pendse's work include Peroxisome Proliferator-Activated Receptors (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Adipose Tissue and Metabolism (3 papers). Avani A. Pendse is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Adipose Tissue and Metabolism (3 papers). Avani A. Pendse collaborates with scholars based in United States and Taiwan. Avani A. Pendse's co-authors include Nobuyo Maeda, Lance A. Johnson, Michael K. Altenburg, José M. Arbones-Mainar, Robert D. Junkins, Alex Petrucelli, Elizabeth Holley-Guthrie, Karen V. Swanson, Glen N. Barber and Jenny P.‐Y. Ting and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Diabetes.

In The Last Decade

Avani A. Pendse

20 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avani A. Pendse United States 9 198 148 74 64 64 24 406
Parker S. Woods United States 14 228 1.2× 180 1.2× 72 1.0× 52 0.8× 102 1.6× 26 674
Annalisa Moregola Italy 11 142 0.7× 183 1.2× 51 0.7× 67 1.0× 80 1.3× 20 410
Paulette A. Krishack United States 9 147 0.7× 122 0.8× 44 0.6× 77 1.2× 65 1.0× 15 390
Urpu Salmenniemi Finland 14 104 0.5× 110 0.7× 68 0.9× 47 0.7× 94 1.5× 40 439
Sara Bruzzaniti Italy 12 161 0.8× 163 1.1× 47 0.6× 67 1.0× 41 0.6× 24 487
Christian Furlan-Freguia United States 9 273 1.4× 169 1.1× 56 0.8× 54 0.8× 113 1.8× 15 682
Ju Rang Woo South Korea 10 247 1.2× 182 1.2× 125 1.7× 63 1.0× 168 2.6× 14 562
Baoyong Zhou China 12 238 1.2× 74 0.5× 42 0.6× 73 1.1× 92 1.4× 40 481
Sipin Tan China 14 336 1.7× 96 0.6× 42 0.6× 54 0.8× 81 1.3× 40 510
Dongxia Ma China 12 113 0.6× 80 0.5× 72 1.0× 105 1.6× 38 0.6× 25 402

Countries citing papers authored by Avani A. Pendse

Since Specialization
Citations

This map shows the geographic impact of Avani A. Pendse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avani A. Pendse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avani A. Pendse more than expected).

Fields of papers citing papers by Avani A. Pendse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avani A. Pendse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avani A. Pendse. The network helps show where Avani A. Pendse may publish in the future.

Co-authorship network of co-authors of Avani A. Pendse

This figure shows the co-authorship network connecting the top 25 collaborators of Avani A. Pendse. A scholar is included among the top collaborators of Avani A. Pendse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avani A. Pendse. Avani A. Pendse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Pendse, Avani A., et al.. (2023). Refractory Cytomegalovirus Colitis Followed by De Novo Inflammatory Bowel Disease Post-Orthotopic Liver Transplantation. ACG Case Reports Journal. 10(12). e01232–e01232.
5.
Ho, Lisa M., Avani A. Pendse, James Ronald, et al.. (2021). Comparison of clinical efficacy, subjective user experience, and safety for two different core biopsy needles, the Achieve® and Marquee®. Abdominal Radiology. 47(8). 2632–2639. 2 indexed citations
7.
Dov, David, Shahar Z. Kovalsky, Jonathan Cohen, et al.. (2019). A Deep-Learning Algorithm for Thyroid Malignancy Prediction From Whole Slide Cytopathology Images.. arXiv (Cornell University). 5 indexed citations
8.
Pendse, Avani A., et al.. (2019). Defying Occam’s Razor: Colonic Luminal Endometriosis in an Adolescent With Crohn's Disease. Journal of Adolescent Health. 66(3). 375–377. 1 indexed citations
9.
Cope, Heidi, Rebecca C. Spillmann, Nicholas Stong, et al.. (2018). Further evidence for the involvement of EFL1 in a Shwachman–Diamond-like syndrome and expansion of the phenotypic features. Molecular Case Studies. 4(5). a003046–a003046. 22 indexed citations
10.
Pendse, Avani A., et al.. (2018). Increased Rate of ASCUS Diagnosis With Concomitant Request for High-Risk Human Papillomavirus Reflex Testing May Be Due to Cognitive Bias. American Journal of Clinical Pathology. 149(5). 425–433. 1 indexed citations
11.
Swanson, Karen V., Robert D. Junkins, Elizabeth Holley-Guthrie, et al.. (2017). A noncanonical function of cGAMP in inflammasome priming and activation. The Journal of Experimental Medicine. 214(12). 3611–3626. 117 indexed citations
12.
Pendse, Avani A., et al.. (2017). Intraosseous Rosai‐Dorfman disease diagnosed by touch imprint cytology evaluation: A case series. Diagnostic Cytopathology. 46(1). 83–87. 3 indexed citations
13.
Pendse, Avani A. & Leslie G. Dodd. (2015). Fine‐needle‐aspiration cytology of a proximal type epithelioid sarcoma: A case report. Diagnostic Cytopathology. 43(10). 859–862. 12 indexed citations
14.
Pendse, Avani A., et al.. (2014). Hemolytic Anemia and Metastatic Carcinoma: Case Report and Literature Review. Laboratory Medicine. 45(2). 132–135. 5 indexed citations
15.
Pendse, Avani A., et al.. (2012). Pro- and Antiatherogenic Effects of a Dominant-Negative P465L Mutation of Peroxisome Proliferator–Activated Receptor-γ in Apolipoprotein E–Null Mic. Arteriosclerosis Thrombosis and Vascular Biology. 32(6). 1436–1444. 4 indexed citations
16.
Pendse, Avani A., Yuri Fedoriw, & Monte S. Willis. (2010). Unexpected Cause of Anemia in a 45-Year-Old Patient With Acute Lymphoblastic Leukemia. Laboratory Medicine. 41(11). 645–648. 2 indexed citations
17.
Pendse, Avani A., Lance A. Johnson, Yau-Sheng Tsai, & Nobuyo Maeda. (2010). Pparg-P465L Mutation Worsens Hyperglycemia in Ins2-Akita Female Mice via Adipose-Specific Insulin Resistance and Storage Dysfunction. Diabetes. 59(11). 2890–2897. 9 indexed citations
18.
Tsai, Yau-Sheng, et al.. (2009). Decreased PPARγ Expression Compromises Perigonadal-Specific Fat Deposition and Insulin Sensitivity. Molecular Endocrinology. 23(11). 1787–1798. 26 indexed citations
19.
Pendse, Avani A., José M. Arbones-Mainar, Lance A. Johnson, Michael K. Altenburg, & Nobuyo Maeda. (2008). Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. Journal of Lipid Research. 50. S178–S182. 128 indexed citations
20.
Tsai, Yau-Sheng, Avani A. Pendse, Sheryl S. Moy, et al.. (2006). A de novo deafwaddler mutation of Pmca2 arising in ES cells and hitchhiking with a targeted modification of the Pparg gene. Mammalian Genome. 17(7). 716–722. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026